Tag: COVID-19

T cells can attack many coronavirus targets, even on new variants

Editor's Note This study by researchers at La Jolla Institute for Immunology, La Jolla, California, finds that T cells fight SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the spike protein. By attacking the virus from many angles, the T cells can…

Read More

By: Judy Mathias
January 28, 2021
Share

FDA reduces N95 decontamination cycles from 20 to 4

Editor's Note The Food & Drug Administration (FDA), on January 22, lowered the number of times an N95 mask can be cleaned and reused to 4, down from a previous maximum of 20 reuses, the January 25 Fierce Biotec reports. The FDA reissued emergency use authorizations for 10 N95 decontamination…

Read More

By: Judy Mathias
January 28, 2021
Share

Effects of COVID-19 pandemic on pediatric anesthesiologists

Editor's Note This survey of members of the Society for Pediatric Anesthesia finds that COVID-19 has affected the personal and professional lives of pediatric anesthesiologists, with women and non-whites disproportionately affected. Of 561 respondents: 21.7% planned to change their clinical responsibilities, and 10.6% planned to decrease their professional working time…

Read More

By: Judy Mathias
January 27, 2021
Share

Survey finds 71% of employees concerned about vaccine side effects

Editor's Note A Welltok survey of 1,000 adults across the US finds that 71% of employees are worried about COVID-19 vaccine side effects, 60% of Americans have a vaccine brand preference, and 52% are worried about the vaccine supply, the January 25 Human Resource Executive reports. Employers, who are seen…

Read More

By: Judy Mathias
January 27, 2021
Share

Pandemic fatigue affecting mitigation efforts

Editor's Note This study, led by researchers from Johns Hopkins University School of Medicine, Baltimore, analyzed survey responses from 7,705 participants between April 1 and November 24, 2020, on their attitudes and resistance toward COVID-19 mitigation efforts. All US regions experienced decreases in COVID-19 mitigation efforts during this time period,…

Read More

By: Judy Mathias
January 26, 2021
Share

FDA revises EUAs for N95 decontamination systems

Editor's Note The Food and Drug Administration on January 21 reissued emergency use authorizations (EUAs) for 10 systems used to decontaminate N95 respirators used by healthcare personnel . The 10 systems are: Michigan State University Decontamination System Technical Safety Services VHP Decontamination System Stryker Sustainability Solutions VHP Decontamination System STERIS…

Read More

By: Judy Mathias
January 26, 2021
Share

CDC: Anaphylactic reactions after first dose of Pfizer-BioNTech vaccine

Editor's Note From December 14 to 23, 2020, after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) identified 21 case reports of anaphylaxis. Of those, 4 (19%) were hospitalized (including 3 in intensive care), and 17 (81%) were treated in…

Read More

By: Judy Mathias
January 25, 2021
Share

More than 800 rural hospitals at risk of closure

Editor's Note A report from the Center for Healthcare Quality and Payment Reforms finds more than 800 rural hospitals—40% of rural hospitals in the US—are either at immediate or high risk of closure. The more than 300 rural hospitals at high risk of closure have low financial reserves or high…

Read More

By: Judy Mathias
January 25, 2021
Share

New negative-pressure ventilator to help treat COVID-19 patients

Editor's Note A new negative-pressure ventilatory support device, similar to the “iron lung” used to treat polio patients in the 1950s, provides an additional treatment option for COVID-19 patients, finds this study by researchers in the UK’s Exovent Task Force, formed in March 2020 in response to the COVID-19 pandemic.…

Read More

By: Judy Mathias
January 21, 2021
Share

Study provides evidence that vaccines protect against new COVID-19 variants

Editor's Note A study, led by researchers from Rockefeller University in New York City, finds that volunteers vaccinated with either the Moderna or the Pfizer/BioNTech vaccine will be protected against new variants of the COVID-19 virus. The researchers tested plasma taken from 20 volunteers who had received both doses of…

Read More

By: Judy Mathias
January 21, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat